LOGIN TO YOUR ACCOUNT

Username
Password
Remember Me
Or use your Academic/Social account:

CREATE AN ACCOUNT

Or use your Academic/Social account:

Congratulations!

You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.

Important!

Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message

CREATE AN ACCOUNT

Name:
Username:
Password:
Verify Password:
E-mail:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Rowlands, Sam; Sujan, Mark-Alexander; Cooke, Matthew (Professor of clinical systems design) (2010)
Publisher: B M J Group
Languages: English
Types: Article
Subjects: RG
Key message points\ud - Appreciation of human factors can provide useful insights into the reduction of risks through intuitive device design and the management of contributory factors in the environment. \ud - Risks of implants relate to the way in which devices are designed and used rather than to their pharmacological properties.\ud - The risks associated with the use of contraceptive implants include non-insertion and deep insertion
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • (4) Darney P. Implantable contraception. European Journal of Contraception & Reproductive Health Care 2000; 5 (Suppl 2):2-11.
    • (5) National Collaborating Centre for Women's and Children's Health. Longacting reversible contraception (NICE guideline). London: RCOG [http://www.nice.org.uk]; 2005.
    • (6) Lader D. Contraception and sexual health, 2008/09. Newport: Information Centre; 2009.
    • (7) Mansour D. Nexplanon® - what Implanon did next. J Fam Plann Reprod Health Care 2010; 36.
    • (8) Summary of Product Characteristics for Implanon http://www.medicines.org.uk/EMC/medicine/5382/SPC/Implanon+68mg+impl ant+for+subdermal+use/. 2009.
    • (9) Mascarenhas L. Insertion and removal of Implanon®. Contraception 1998; 58 (Suppl 6):79S-83S.
    • (10) Rowlands S. Legal aspects of contraceptive implants. J Fam Plann Reprod Health Care 2010; 36.
    • (11) Wenck BCA, Johnston PJ. Implanon and medical indemnity: a case study of risk management using the Australian standard. Med J Aust 2004; 181:117- 119.
    • (12) Mansour D, Fraser IS, Walling M, Glenn D, Graesslin O, Egarter C et al. Methods of accurate localisation of non-palpable subdermal contraceptive implants. J Fam Plann Reprod Health Care 2008; 34:9-12.
    • (13) Good manufacturing practice guidelines. EuraLex Volume 4. Brussels: European Commission; 2009.
    • (14) Edwards JE, Moore A. Implanon: a review of clinical studies. Br J Fam Planning 1999; 24 (Supplement):3-16.
    • (15) Newton J, Newton P. Implanon® - the single-rod subdermal contraceptive implant. J Drug Eval 2003; 1:181-218.
    • (16) Meirik O, Fraser IS, d'Arcangues C. Implantable contraceptives for women. Human Reproduction Update 2003; 9:49-59.
    • (17) Darney P, Patel A, Rosen K, Shapiro LS, Kaunitz AM. Safety and efficacy of a single-rod etonogestrel implant (Implanon): results from 11 international clinical trials. Fertil Steril 2009; 91:1646-1653.
    • (18) Reason J. Managing the risks of organizational accidents. London: Ashgate; 1997.
    • (19) Norman DA. The psychology of everyday things. New York: Basic Books; 1987.
    • (20) Vincent C, Taylor-Adams S, Stanhope N. Framework for analysing risk and safety in clinical medicine. BMJ 1998; 316:1154-1157.
    • (21) BS EN 62366 Medical devices - application of usability engineering to medical devices. Bristol: British Standards Institution; 2008.
    • (22) Walling M. How to remove impalpable Implanon® implants. J Fam Plann Reprod Health Care 2005; 31:320-321.
    • (23) Mansour D, Mommers E, Teede H, Sollie-Eriksen B, Graesslin O, Ahrendt HJ et al. Clinician satisfaction and insertion characteristics of a new applicator to insert radiopaque Implanon: an open-label, noncontrolled, multicenter trial. Contraception 2010; 82:243-249.
  • No related research data.
  • No similar publications.

Share - Bookmark

Cite this article